社论：“构建肿瘤免疫微环境”特刊
Editorial: 'Engineering the Tumor Immune Microenvironment' Special Issue.
作者信息
Ahmad Raffae N, Verbridge Scott S
机构信息
Department of Biomedical Engineering and Mechanics, Virginia Tech, Blacksburg, VA 24061, USA.
出版信息
Cancers (Basel). 2023 Aug 8;15(16):4014. doi: 10.3390/cancers15164014.
Abstract
Cancer immunotherapies, while promising and occasionally even curative, encounter numerous hurdles within the tumor microenvironment that hinder their efficacy [...].
摘要
癌症免疫疗法虽然前景广阔，甚至偶尔能治愈疾病，但在肿瘤微环境中会遇到许多阻碍其疗效的障碍[……]。
相似文献
1
Editorial: 'Engineering the Tumor Immune Microenvironment' Special Issue.
Cancers (Basel). 2023 Aug 8;15(16):4014. doi: 10.3390/cancers15164014.
2
Editorial on Special Issue "Immunotherapy, Tumor Microenvironment and Survival Signaling".
Cancers (Basel). 2021 Dec 24;14(1):91. doi: 10.3390/cancers14010091.
3
Guest Editorial: what can be done to improve cancer immunotherapies?
Int J Hematol. 2023 May;117(5):631-633. doi: 10.1007/s12185-023-03578-y. Epub 2023 Mar 25.
4
Editorial: The intricate innate immune-cancer cell relationship in the context of tumor angiogenesis, immunity and microbiota: The angiogenic switch in the tumor microenvironment as a key target for immunotherapies.
Front Immunol. 2022 Oct 6;13:1045074. doi: 10.3389/fimmu.2022.1045074. eCollection 2022.
5
Role for extracellular vesicles in the tumour microenvironment.
Philos Trans R Soc Lond B Biol Sci. 2018 Jan 5;373(1737). doi: 10.1098/rstb.2016.0488.
6
Engineering Nanoparticles to Reprogram the Tumor Immune Microenvironment for Improved Cancer Immunotherapy.
Theranostics. 2019 Oct 17;9(26):7981-8000. doi: 10.7150/thno.37568. eCollection 2019.
7
Royal Society Scientific Meeting: Extracellular vesicles in the tumour microenvironment.
Philos Trans R Soc Lond B Biol Sci. 2018 Jan 5;373(1737). doi: 10.1098/rstb.2017.0066.
8
Erratum to: 'Hedgehog signaling: modulation of cancer properties and tumor microenvironment'.
Mol Cancer. 2016 May 11;15(1):35. doi: 10.1186/s12943-016-0522-6.
9
Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms.
Front Immunol. 2022 Jun 2;13:939789. doi: 10.3389/fimmu.2022.939789. eCollection 2022.
10
Pancreatic cancer: Hurdles in the engineering of CAR-based immunotherapies.
Oncoimmunology. 2014 Jun 18;3:e29194. doi: 10.4161/onci.29194. eCollection 2014.
本文引用的文献
1
Engineering the Tumor Immune Microenvironment through Minimally Invasive Interventions.
Cancers (Basel). 2022 Dec 29;15(1):196. doi: 10.3390/cancers15010196.
2
5-Azacytidine-Mediated Modulation of the Immune Microenvironment in Murine Acute Myeloid Leukemia.
Cancers (Basel). 2022 Dec 25;15(1):118. doi: 10.3390/cancers15010118.
3
Targeted Depletion of Hyaluronic Acid Mitigates Murine Breast Cancer Growth.
Cancers (Basel). 2022 Sep 23;14(19):4614. doi: 10.3390/cancers14194614.
4
Paving the Way to Solid Tumors: Challenges and Strategies for Adoptively Transferred Transgenic T Cells in the Tumor Microenvironment.
Cancers (Basel). 2022 Aug 29;14(17):4192. doi: 10.3390/cancers14174192.
5
Temsirolimus Enhances Anti-Cancer Immunity by Inducing Autophagy-Mediated Degradation of the Secretion of Small Extracellular Vesicle PD-L1.
Cancers (Basel). 2022 Aug 23;14(17):4081. doi: 10.3390/cancers14174081.
6
Local Breast Microbiota: A "New" Player on the Block.
Cancers (Basel). 2022 Aug 5;14(15):3811. doi: 10.3390/cancers14153811.
7
Tertiary Lymphoid Structures as Mediators of Immunotherapy Response.
Cancers (Basel). 2022 Aug 1;14(15):3748. doi: 10.3390/cancers14153748.
8
The Route of the Malignant Plasma Cell in Its Survival Niche: Exploring "Multiple Myelomas".
Cancers (Basel). 2022 Jul 4;14(13):3271. doi: 10.3390/cancers14133271.
9
Myeloid Derived Suppressor Cells Migrate in Response to Flow and Lymphatic Endothelial Cell Interaction in the Breast Tumor Microenvironment.
Cancers (Basel). 2022 Jun 18;14(12):3008. doi: 10.3390/cancers14123008.
10
Targeting Immunosuppressive Tumor-Associated Macrophages Using Innate T Cells for Enhanced Antitumor Reactivity.
Cancers (Basel). 2022 Jun 1;14(11):2749. doi: 10.3390/cancers14112749.
Zotero 插件